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The Importance of Epithelial Uptake
Systems in Lung Toxicity
by Lewis L. Smith,* Christian P. L. Lewis,* Ian Wyatt,*
and Gerald M. Cohent
The discovery that the herbicide paraquat was selectively accumulated by the lung, both in vivo and
in vitro, incomparisonwithothertissues, providedanexplanationforitsselectivetoxicitytothelung.
Thisuptakeprocessisenergydependentandobeyssaturationkinetics. Acharacterizationoftheprocess
ledtotheidentificationofendogenouschemicalsthatarethenaturalsubstratesforthesystem. Among
these are a series ofdiamines and polyamines, as well as the diaminodisulfide cystamine. It appears
thatparaquat, becauseofspecificstructuralsimilaritiestotheseendogenouspolyamines, ismistakenly
accumulated by the lung. This uptake process is specifically located in the alveolar Type II cell, the
Clara cell, and probably the alveolar Type I cell.
Withthe developmentofknowledge ofthe structuralrequirements ofchemicals tobe accumulated
by this system, it is possible to predict which chemicals will be accumulated by the lung or design
molecules that are targeted to the alveolar epithelial and Clara cells.
In the wider perspective, this polyamine uptake system has been found on a number of cancerous
cells or tissues. With the knowledge ofthe uptake system in the lung, it should be possible to design
drugs that will be specifically concentrated in cells that possess this system.
Introduction
Because the lung is responsible for all gas exchange
necessary for oxidative metabolism, it is inevitably ex-
posed to toxic gases, vapors, and particles (if small
enough) present in the atmosphere. The respiratory
functionofthelungrequiresalargesurfacearea(inman,
about the size of a tennis court) that, on the airside, is
coveredbyepithelial cellsintimatelyassociatedwith an
extensivecapillarynetwork. Apartfrominhalation, the
lungisalso exposedtotoxiccompoundsthathavebeen
absorbed into the bloodstream or are in the form of
metabolites, formed either in the lung or in extrapul-
monary tissue.
In orderto meet itsrespiratory function, the lung re-
quires numerous celltypes. Morethan40 celltypeshave
beenidentifiedinthelung(1); these arerequiredtopro-
videthe diverse architecture associated withcartilage,
smooth muscle, connective tissue, submucosal glands,
the vascular system, and the respiratory unit (alveoli)
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(2). Extensive literaturedescribesthe normalarchitec-
ture ofthe lung and the interrlationships which occur
between the numerous cell types (2).
The selective vulnerability of lung cells to toxins
dependsonavarietyoffactors. Therouteofadministra-
tionofatoxicant, differencesinthemetabolismofatoxi-
cant within individual cell types, or differences in the
biochemicalfunctionofindividualcelltypesmayallcon-
tribute torenderingparticularcelltypes susceptible to
an individual chemical (3). In this review we intend to
concentrate onthe characterization ofaparticular up-
take system in specific lungcells that isresponsible for
theaccumulationofvariousendogenousandexogenous
chemicals. Readersshallseethatthepresenceofthisup-
take system allows specific epithelial cells to become a
victim of selective damage, although the same system
mayalsoprove usefulintargetingspecificchemicalsto
individual cells for therapeutic purposes.
Background
Inthelast25yearstherehavebeenanumberofhuman
fatalitiesasaconsequenceoftheingestionof theherbi-
cide paraquat (1,1' -dimethyl-4,4' -bipyridilium) (4).
Thesefatalitieshaveresulted largely asaconsequence
ofthe intentionalingestionoftheconcentratedcommer-
cial product. When it is swallowed, the symptoms ofSMITHETAL.
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poisoningdependlargelyontheamountconsumed. Pa-
tientswhodie withinafewdaysofitsingestiondevelop
multiorganfailureassociated withadrenaldamage, liver
damage, kidneydamage, cerebralhemorrhage, andlung
damage(5). In these casestheprecise cause ofdeath is
difficulttoestablishsincesomanyvitalorganshavebeen
destroyed. However, patientswhosurviveformanydays
orweeksafteringestionandthensuccumbtothetoxin
usually die directly orindirectly as aresult ofselective
damage to the lung (5).
There are two distinct phases in the development of
lung lesions provoked by paraquat (6). The first is a
destructive phase in which the alveolar type I and
Type II epithelial cells are damaged within a few days
ofpoisoning(6). Ifthisdamageisextensive, analveolitis
develops and is associated with frank hemorrhage,
edema, and the infiltration of inflammatory cells into
the interstitial and alveolar spaces of the lung. When
paraquatisgiventoexperimentalanimals(e.g., therat),
manywilldiewithinthefirstfewdaysofdosingasacon-
sequenceofthisalveolitis. Althoughtherehavebeenoc-
casional reports ofendothelial celldamage inthe lung,
it is generally accepted that the primary target cells of
paraquat are those of the alveolar epithelium (6).
The second phase ofthe lung lesion is characterized
byanextensive proliferative fibrosis(6). In experimen-
tal animals or humans who develop an extensive
alveolitis but do not succumb duringthe first few days
ofpoisoning, afibrosisdevelopsthatcanbe sosevere as
todestroy the normalarchitecture ofthe lungand lead
to death from anoxia (6). This fibrosis can be regarded
as aconsequence ofthe acute destructive phase and is
probably part ofthe normal reparative response ofthe
lung.
In one of the earliest experiments carried out to in-
vestigate the mechanism ofparaquat toxicity in rats, it
wasfoundthatafteroraladministrationtheplasmacon-
centrationofparaquatremainedrelativelyconstantover
aperiodof30hr, whereastheconcentration inthelung
roseprogressivelytoseveraltimesthatintheplasma(7)
(Fig. 1). In no other organ studied was this time-
dependentaccumulationofparaquatseen(8).Thisselec-
tive accumulation, in part, explained the selective
toxicity ofparaquat to the lung, since it was this organ
that achieved the highest concentrations of paraquat
after oral dosing (8). The only exception is the kidney
thatwasfoundtocontainhighconcentrations(8), since
it is the route of excretion of paraquat. However, the
disposition of paraquat in the kidney is a result of
glomerularfiltration, ratherthanaselectiveaccumula-
tion as seen in the lung.
In order to investigate the accumulation ofparaquat
into lung, Rose et al. (9) studied its uptake into rat lung
slices. Usingthismethod, theyfoundthatparaquatwas
accumulatedinatime-dependentmannerintoslicesby
aprocessthatwasenergy-dependentandobeyedsatura-
tionkinetics(9). Consequently, itispossibletoderivean
apparent Km of 70 uM and a Vmax of 300 nmole para-
quat/g lung hr (9). The accumulation of paraquat into
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FIGURE 1. Rats were orally dosed with 680 jtmole of paraquat/kg
bodywtandthelung(A)andplasma(e)levelsofparaquatdeter-
mined. Each time point represents the mean ± SE for five rats.
tissue slices taken from various organs of the rat
demonstrated that, apart from the lung, the brain cor-
texistheonlyothertissueabletoaccumulateparaquat
(8). However, theuptakeofparaquatintothebrainonly
occursinvitro, sincethereisnoretention oraccumula-
tionofparaquatinthebrain, invivo(8).Thisdifference
islikelytobeduetotheblood-brainbarrierthatprevents
accumulation in vivo but would not be relevant to in
vitrostudies. Thediscoverythatparaquatwasaccumu-
latedintothelungledtothesearchforendogenouscom-
poundsthatarepresentintheplasmaorlungandcould
be the natural substrate for the uptake system.
Uptake System Responsible for the
Accumulation of Paraquat
In an attempt to identify possible endogenous com-
poundsthatcouldbethenaturalsubstratefortheuptake
system inthe lung, the ability ofputative substrates to
inhibit the uptake of paraquat into lung slices was
investigated. Awidevarietyofcompoundsweretested,
but among the most effective inhibitors of paraquat
accumulationwereaseriesofdiaminesandpolyamines
(lible 1)(10). Paraquatuptakeisreducedinthepresence
of the diamine putrescine, and this reduction was
dependent on the putrescine concentration (11).
Putrescineitselfwasfoundtoaccumulateintolungslices
in alinear, time-dependent mannerby aprocessthatis
both energy dependent and obeys saturation kinetics
(11). Theseobservationsledtothesuggestionthatthere
iscompetitionbetweenparaquatandputrescineforan
uptake process in the lung. As with paraquat, it was
possible to derive an apparentKm forthe accumulation
ofputrescine. This was found to be 7 jiM(11) which is
approximately 10-foldlowerthanthatforparaquat, indi-
cating that the endogenous substrate has a greater
affinityfortheuptakeprocessthandoesparaquat. The
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Tkble 1. The effectofdiaminesandpolyaminesontheaccumula-
tion ofparaquat into rat lung slices.a
Compound Structure % of control
Cystamine NH2(CH2)2S-S(CH2)2NH2 58
Putrescine NH2(CH2)4NH2 31
Cadaverine NH2(CH2)5NH2 65
Hexamethylenediamine NH2(CH2)6NH2 29
Decamethylenediamine NH2(CH2)10NH2 19
Spermidine NH2(CH2)4NH(CH2)3NH2 71
Spermine NH2(CH2)3NH(CH2)4NH(CH2)3NH2 54
aSlicesofratlungwereincubated inKrebs-Ringerphosphate(KRP)
glucose medium(37OC)containing 10 uM [14CJparaquattogetherwith
10,uMoftestcompound. Theaccumulationofparaquatwasmonitored
over90min, thelinearrateofparaquat uptakedetermined, andthe
results expressed as the percentage of the control rate, which was
33 ± nmole paraquat/g wet wt/hr.
Vmax for the uptake of paraquat and putrescine were
almostidentical, suggestingthatthereisasinglesystem
responsiblefortheaccumulationofbothcompounds(11).
In addition to putrescine, a series of diamines and
polyamines were found to use this uptake system (12).
This leads to the conclusion that a polyamine uptake
system is present in the lung that is capable of accum-
ulating paraquat, such that when paraquat is absorbed
into the bloodstream it circulates to the lung and is
mistakenly accumulated forthe naturalsubstrates, the
polyamines (11). Since, as stated previously, there are
more than 40 different cell types in the lung, it was
important to identify which cell (or cells) was respon-
sible for this uptake process.
Location of the Uptake System
in the Lung
Theobservationthatparaquatselectivelydamagedthe
alveolar Type Iand Type IIepithelial cellsandtheClara
cellsofthelungprovided aninitialhypothesisthatthese
cell types may well be the compartments into which
paraquat is accumulated. The first report to use
autoradiographic techniques to visualize the compart-
ment indicated that tritiated paraquat was confined
almost entirely to cells having the typical distribution
ofalveolar TypeII cells(13). Recently, ithasbeenshown
that in lung slices incubated with tritiated putrescine,
spermidine, or spermine the label is concentrated in
Claracells, whereasadjacentciliated cellsremainalmost
entirelyunlabeled (14,15). Thealveolar Type HceUs are
also specifically labeled and there is diffuse label on or
nearthealveolar TypeIepithelialcells. Itisnotpossible
withtheresolutionofthelightmicroscopetobecategoric
that this cell type has accumulated the polyamines
(14,15). However, since the Type I cell is damaged with
paraquat and there is an absence of labeling in the
vascular endothelium lining the larger blood vessels, it
seemsreasonabletoconclude thiscellalsoaccumulates
putrescine and, by analogy, paraquat (15).
Differences are seenbetweenthe useoflungslicesin
vitro, and perfused lungand lung invivo studies. With
the perfused lungand the lung in vivo, labeled putres-
cine, spermidine, and spermine were only found in the
alveolarTypeIIcell; nolabelwasseeneitherintheClara
celloroverareasofthealveolusassociatedwiththeType
Icell(14). Thismayreflectarealdifferenceinthedistri-
butionofparaquatandthepolyaminesbetweeninvitro
and in vivo systems (14). However, the authors con-
cluded thatthe difference is more likely to be attribut-
abletodifferencesinthespecificactivityofthelabeled
compounds that can be given in vitro compared with
invivo(14). Withthe lungslicetechnique, it ispossible
to expose lung cells to labeled compound of a high
specificactivity, whereaswithboththeperfusedandin
vivo lung, this is not the case (14).
In conclusion, the polyamines are accumulated into
perfused lung and into the lung in vivo, as well as into
lungslices invitro. Thisaccumulation certainly occurs
in the alveolar Type II cell, the Clara cell, and very
probably the alveolar Type I cell. By analogy, it can be
arguedthatparaquatisalsoaccumulatedintothesecell
types.
Other Substrates for the Polyamine
Uptake System
Studies in this laboratory have shown that the
physiologically occurringthiol cysteamine is able to in-
hibit the uptake of paraquat into lung slices (16).
However, itisknownthatinplasmaorextracellularfluid,
cysteamine will at least, in part, be oxidized to the
disulfide cystamine (16). Moreover, since cysteamine is
a monoamine that is known not to use the transport
system, itseemedlikelythatcystamine, whichdoesmeet
the criteria for uptake via the polyamine system, may
itself be accumulated. This is indeed the case (16,17).
Cysteamineisnotabletoinhibittheuptakeofparaquat
into lung slices if the cysteamine sulfhydryl group is
stabilized by the addition ofdithiothreitol(DTT) to the
incubation medium. When cysteamine undergoes
autooxidation in the medium to cystamine, it is able to
inhibit paraquat uptake (16). Cystamine accumulation
into lung has been directly measured (16,17) and it ap-
pears to result from two separate processes with dif-
ferentkineticparameters(16,17). Ahigh-affinitysystem
has been identified, and this appears to be responsible
forthe uptake ofpolyamines(16,17). The system obeys
saturationkineticsandisenergydependent(16,17). The
identificationofacystamineuptakesystemintothelung
raisesthequestionastowhetherthis, orthepolyamines,
or both are primary substrates for the uptake process.
Since the polyamines were the first endogenous
substratesidentified tousethisprocess, thesystem has
becomeknownasapolyamineuptakesysteminthelung,
However, there are compelling reasons to suggest that
cystamine istheprime substrate fortheuptakeprocess
inthealveolarepithelialcells. Onaccumulationintothe
lung, cystamine israpidlymetabolizedtotaurine(16,17).
This is the major metabolite for both the high-affinity
and low-affinity systems (16,17).
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Thetaurine that isformed inthelungiswhollyretain-
ed as taurine, suggesting an endogenous function for
taurineinthelung(16). Taurineisfoundinhigh concen-
trationsinseveraltissuesthatgeneratereactive oxygen
species, and amongitsothereffectsitisknownto possess
antioxidant properties (18). Moreover, severaldisulfides
including cystamine have been suggested to have the
potential toregulate cellularNADPHlevels in response
to oxidative stress (19). Since the apparent Km for the
pulmonary uptake ofcystamine (12 AM)issimilartothe
plasma concentration of the disulfide (20), it seems
plausible to suggest that in vitro this uptake system is,
in part, responsible for the accumulation of cystamine
and, consequently, the presence oftaurine in the lung.
Itisplausibletosuggestthatbothcompoundsact asanti-
oxidants in the lung. This would be consistent with the
known requirement of the lung to maintain, at its
epithelial cell surface, an adequate defense against the
oxidative stress caused by the continuous exposure to
high concentrations of oxygen.
Targeting of Radioprotective
Agents to the Lung
Since the structural requirement forchemicals to act
assubstratesforthepolyamine uptake systemhasbeen
investigated(21), itispossible topredictthose structures
that arelikelytohavetherequirementsforaccumulation
bythelung. The moreeffectivesubstrates arethosewith
at least four methylene groups between quaternary
nitrogenatoms(putrescine, cadaverine, etc.). Theirmax-
imum inhibitory potency was found when there were
between 7 and 10 methylene groups (10). So far, it has
not been possible to establish the optimum separation
between the nitrogen atoms. However, the minimum
separation appearstobein excessof0.5 mn(22). Wehave
found that the radioprotective compound WR2721
[S-2(3-aminopropylamino)ethyl phosphorothioate] can
act as a substrate for the uptake system (23). However,
theseparationofthenitrogenatomsinWR2721bythree
methylene groups suggested that this molecule would
be a relatively poor substrate.
The ability of a series of S-2(aminoalkylamino)ethyl
phosphorothioates to competitively inhibit the uptake
of putrescine into the lung has been measured and
used as an indirect measure of the ability of these
radioprotectors themselves to be accumulated into
the lung (23). The substrates used were WR2721
and S-2(4-aminobutylamino)ethyl phosphorothioate
(S-ABEP) and S-2(7-aminoheptylamino)ethyl phos-
phorothioate (S-AHEP) (23). Their inhibitory potency
tended to increase as the number ofmethylene groups
between the nitrogen atoms increased (Thble 2). The
apparent Km for putrescine accumulation into lung
slices is approximately 15 AM whereas the Ki values
determined forWR2721, S-ABEP, andS-AHEP were48,
57, and 7 ttM, respectively (23). Since the inhibition of
putrescine accumulation by these phosphorothioates
was competitive (Fig. 2), it can be argued that the
Table 2. The effect of the S-2-(aminoalkylamino)ethyl
phosphorothioate radioprotectors on the accumulation
of putrescine into lung slices.a
Compound Structure Ki, AM
WR2721 NH2(CH2)3NH(CH2)2 S 48
S-2-(3-Aminopropylamino) O=P-OH 48
ethyl phosphorothioate
OH
S-ABEP NH2(CH2)4NH(CH2)2 S
S-2-(4-Aminobutylamino) O=P-OH 57
ethyl phosphorothioate
OH
S-2-(7-Aminopeptylamino) NH2(CH2)7NH(CH2)2 S
S-2-(7-Aminopeptylamino) O=P-OH 7
ethyl phosphorothioate
OH
aThe inhibitory constants werederived fromthe Lineweaver-Burk
plots of[14C]putrescine uptakeintolungslicesinthepresenceof 100
MAM WR2721, 50MuM S-ABEP, or 10 AM S-AHEP. The inhibitory con-
stantsweredetermined usingthemethodofDixonandWebbforcom-
petitive inhibition. The linear regression correlation coefficient for
all plots was greater than 0.9.
apparentKm forthe uptake ofthese chemicals would be
48, 57, and 7 ,uM, respectively.
Asstatedpreviously, wehaveshownthatcysteamine
israpidlyconvertedtothedisulfidecystamineunderthe
conditions for investigating its accumulation into lung
slices. The oxidation of cysteamine and, consequently,
itsabilitytocompetefortheuptakesite, ispreventedif
DTTispresentintheincubationmedium, sincethismain-
tains the cysteamine as a monoamine containing a
sulfhydryl group (16). In the absence of DTT the
cysteamine isoxidized tocystamine(16). Since WR2721
israpidlydephosphorylated byalkalinephosphatase to
form the free thiolN-2-mercaptoethyl-1,3-diaminopro-
pane (24), by analogy with cysteamine these dephos-
phorylated radioprotectors may be oxidized to the
disulfide intheabsenceofDTT. Thatthisisthe case can
be demonstrated by the effect of DTT on the ability of
WR2721 toinhibitputrescineaccumulationintothelung.
The apparent K. was increased from 48 zM in the
absenceofDTTto 155AMinitspresence, indicatingthat
asthesulfhydrylWR2721 wasalessadequatesubstrate
for the uptake system (23). Similarly, theKi ofS-ABEP
was increased from 57 to 88 AM and theKiofS-AHEP
from7AMto 15AtM(23).Theseresultsareindicativethat
thefreethiolsarespontaneouslyoxidizedtothedisulfide
in the incubation medium, and that these radioprotec-
torsinthisformaremoreeffectiveatcompetingforthe
uptakesite. Thissuggeststhatthetransport receptorin
the lung recognizes the diamine structure in either its
free thiol or disulfide form, although chemicals act as
more effective substrates in a disulfide form probably
as a result of the greater separation between the
nitrogens.
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FIGURE 2. The kinetic profile for the uptake of ['4C]putrescine into lung slices in the presence of (A) WR2721, (B) S-ABEP, and (C) S-
AHEP. ( U-U-U) control, (A-A-A) 10 AM, (- .- ) 25 AM, and ( V-V-V ) 100 AM depicted by Lineweaver-Burk plots. Each point
was the mean of three observations.
These results, together with a greater understanding
ofthestructuralrequirementsforsubstrates to usethis
uptakesystem, suggestit maybepossibletotarget awide
variety of chemicals to the alveolar Type I and Type II
cells and Clara cells ofthe lung. It is clear thatby alter-
ing the number of methylene groups separating the
amine groups in the substrate, it is possible to alter the
affinity ofthe chemicalfortheuptake process. It seems
reasonable to argue that S-ABEP and S-AHEP may be
moreeffectivelyaccumulatedbythelungthanWR2721,
thereby providing a more targeted and, consequently,
more affective radioprotection (23).
However, afeature ofthekineticsassociated withthis
transport process indicates that there are differences
between in vitro and in vivo studies. We know that in
the caseofparaquat, followingoraldosingtorats, ittakes
manyhoursofrelatively constantconcentrations inthe
plasmatoachievehighconcentrationsofparaquatinthe
lung(7). Similarlywithputrescine, itismanyhoursbefore
the lungaccumulates concentrations in excess ofthose
foundintheplasma(14). The reasonsforthe difference
between in vivo and in vitro kinetics are not fully
understood. They are likely to include the presence of
otherendogenoussubstratesintheplasmainvivo, com-
pared with invitro studies, and the likelihood that the
exposure ofthe substrate to the lung epithelial cells in
vitro is considerably greater than that following in
vivodosinginwhichthesubstrateisdeliveredtothelung
via the endothelial capillary network. This means that
to optimize the targeting ofradioprotectors to the lung
invivo, it maybenecessarytoadministerthecompounds
so that they are present in the plasma for many hours
and so that the concentration is in the range of the ap-
parent Km for the transport process. This suggestion is
in contrast tothe currentregime forthe administration
ofWR2721 topatientspriortoradiation orchemotherapy
treatment for malignancy (24). Moreover, if the results
from in vitro studies are relevant to the in vivo situa-
tion, thenWR2721 doesnothavetheoptimummolecular
structure to use the polyamine transport process; S-
ABEP and S-AHEP have a higher affinity for the
transport system than WR2721.
General Perspective
An examination of the wide range of chemicals that
canact aspulmonarytoxicantsrevealsthephenomenon
ofselective toxicity to individual cell types in the lung.
This selective toxicity depends on a number of factors
such as the route of administration of the toxicant, its
disposition, metabolism, and the specific biochemical
and physiological characteristics of the individual cell
typeswherethetoxicantistargeted. Inthisbriefarticle
I have attempted to highlight the role of a polyamine
accumulation system in specific epithelial cells of the
lung in determining the selective toxicity of the her-
bicide paraquat. It is the concentration of this toxicant
in specific lung cells that leads to selective damage to
these cells and, consequently, the observable selective
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toxicity in pulmonary tissue. Perhaps more important
than therole ofthesysteminleadingtoselectivetoxici-
ty is the possibility that it can be exploited for the
delivery of selected molecules to individual epithelial
cellsinthelung. Sofar, onlytheradioprotectorsWR2721
and its analogues have been investigated, but from the
structural requirements forthissystem, it ispossible to
predict awide range ofsubstrates that are likely to use
this up take system.
Inthewiderperspective, thelungisnottheonlyorgan
with the ability to accumulate polyamines. Polyamine
accumulation has been described in the brain (12),
salivaryglands(25), seminalvesicles(25), nontransform-
edAD3white cells(25), murineleukemicWEHI3white
cells(25), prostaticcancercells(26), neuroblastomacells
(27), andascitesL1210leukemiccells(28). Itappearsthat
the system described inthose various celltypes is iden-
tical orverysimilartothatwhichhasbeendescribedin
the lung. Theoretically, it should be possible to target a
diverse range of substrates that meet the structural
requirementsforthepolyamine uptake systemtothese
individual cell types, offering the possibility of design-
ingcytotoxicdrugsthatwillbeselectivelyaccumulated
by cancer cell types that possess the polyamine uptake
system.
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